Henkel has introduced two next-generation medical grade, cyanoacrylates-based instant adhesives that offer improved safety and performance. The new products are formulated without CMR (Carcinogenic, Mutagenic or Reproductively hazardous) ingredients and are designed to offer increased strength during and after heat cycling. Loctite 4011S and Loctite 4061S are designed to meet the specifications of Loctite 4011 and 4061 for easier validation in existing medical applications.

Both new products have been tested to ISO 10993 biocompatibility standards. The adhesives develop handling strength in seconds on most substrates and provide high bond strength on a range of materials. After 1000 hours of exposure to 248°F (120°C) heat, these next generation adhesives offer approximately 100% greater shear strength on steel than other instant adhesive formulations.

“Henkel is committed to medical quality systems and good manufacturing practices as a pioneer for sustainable solutions,” said Philipp Loosen, vice president and head of Industrials EIMEA and Global Key Accounts Medical at Henkel. “The launch of these new, next generation instant adhesive are formulated to meet the highest safety standards, addressing the need for safe and effective medical device assemblies, and demonstrating our longstanding commitment to the medical industry.”

To learn more, visit www.henkel.com.